Bin-Nan Wu Selected Research

Bin-Nan Wu Research Topics

Disease

9	Inflammation (Inflammations) 10/2021 - 06/2011
7	Hyperglycemia 01/2022 - 01/2015
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2016
7	Neuralgia (Stump Neuralgia) 11/2021 - 05/2014
6	Hypertension (High Blood Pressure) 02/2022 - 06/2010
5	Cardiovascular Diseases (Cardiovascular Disease) 02/2022 - 01/2020
5	Hyperalgesia 11/2021 - 05/2014
5	Pulmonary Hypertension 01/2021 - 11/2010
5	Body Weight (Weight, Body) 09/2018 - 04/2009
5	Right Ventricular Hypertrophy 05/2015 - 05/2010
4	Hyperlipidemias (Hyperlipidemia) 01/2022 - 03/2014
4	Obesity 01/2022 - 04/2009
4	Pain (Aches) 10/2021 - 05/2014
4	Vascular Remodeling 01/2021 - 11/2010
4	Pulmonary Arterial Hypertension 01/2021 - 05/2010
3	Atrial Fibrillation 02/2022 - 01/2016
3	Myocardial Infarction 02/2022 - 01/2011
3	Fibrosis (Cirrhosis) 08/2021 - 03/2010
3	Neuroinflammatory Diseases 02/2020 - 06/2015
3	Left Ventricular Dysfunction 01/2020 - 01/2011
3	Hypoxia (Hypoxemia) 01/2019 - 05/2015
3	Necrosis 06/2011 - 08/2004
2	Vascular Calcification 05/2022 - 10/2020
2	Type 2 Diabetes Mellitus (MODY) 02/2022 - 01/2022
2	Cardiac Arrhythmias (Arrythmia) 02/2022 - 08/2020
2	Weight Gain 01/2022 - 04/2009
2	Insulin Resistance 10/2021 - 01/2018
2	Stress Urinary Incontinence 09/2021 - 01/2020
2	Overactive Urinary Bladder (Overactive Bladder) 08/2021 - 01/2018
2	Diabetes Mellitus 04/2021 - 03/2018
2	Cardiomegaly (Heart Hypertrophy) 06/2019 - 03/2010
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2014 - 08/2012
2	Hyperplasia 01/2014 - 09/2007
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2014 - 05/2009
2	Hypertrophy 01/2013 - 03/2010
2	Hypotension (Low Blood Pressure) 01/2005 - 09/2004

Drug/Important Bio-Agent (IBA)

21	KMUP 1IBA 05/2021 - 09/2007
12	Proteins (Proteins, Gene)FDA Link 11/2021 - 06/2011
9	eugenosedin-AIBA 01/2022 - 01/2005
9	rho-Associated KinasesIBA 01/2017 - 05/2010
8	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 04/2009
7	XanthineIBA 01/2021 - 03/2010
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2020 - 06/2007
5	Theophylline (Theon)FDA LinkGeneric 04/2019 - 05/2014
5	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2017 - 11/2010
4	Matrix Metalloproteinases (MMPs)IBA 05/2021 - 01/2011
4	LipidsIBA 04/2021 - 04/2009
4	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 04/2019 - 03/2010
4	Endothelin-1 (Endothelin 1)IBA 01/2019 - 01/2014
3	Sodium-Glucose Transporter 2 InhibitorsIBA 02/2022 - 08/2020
3	Sodium-Glucose Transporter 2IBA 02/2022 - 08/2020
3	Streptozocin (Streptozotocin)FDA Link 01/2022 - 03/2018
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2005
3	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2022 - 03/2018
3	Glyburide (Glibenclamide)FDA LinkGeneric 01/2022 - 08/2020
3	loganinIBA 11/2021 - 02/2020
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 09/2018 - 06/2014
3	Insulin (Novolin)FDA Link 03/2018 - 04/2009
3	chlorobenzeneIBA 12/2016 - 05/2014
3	MonocrotalineIBA 12/2016 - 05/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2016 - 08/2004
3	Atorvastatin (Lipitor)FDA Link 06/2016 - 06/2011
3	Soluble Guanylyl CyclaseIBA 05/2015 - 06/2010
2	KATP ChannelsIBA 01/2022 - 08/2018
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 08/2018
2	InflammasomesIBA 11/2021 - 01/2020
2	NLR ProteinsIBA 11/2021 - 01/2020
2	IridoidsIBA 11/2021 - 10/2021
2	GlycosidesIBA 11/2021 - 10/2021
2	Superoxide DismutaseIBA 10/2021 - 07/2020
2	Hormones (Hormone)IBA 08/2021 - 01/2018
2	empagliflozinIBA 06/2021 - 08/2020
2	Interleukin-6 (Interleukin 6)IBA 05/2021 - 01/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 05/2015
2	AngiotensinsIBA 01/2021 - 01/2020
2	Angiotensin-Converting Enzyme 2IBA 01/2021 - 01/2020
2	Vasoconstrictor AgentsIBA 01/2021 - 01/2014
2	diminazene aceturateIBA 01/2021 - 01/2020
2	Oxidoreductases (Dehydrogenase)IBA 07/2020 - 01/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2020 - 01/2020
2	CytokinesIBA 02/2020 - 09/2004
2	CalciumIBA 06/2019 - 04/2019
2	CalcineurinIBA 06/2019 - 03/2010
2	VLDL LipoproteinsIBA 06/2019 - 01/2017
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2019 - 03/2010
2	GuanosineIBA 04/2019 - 03/2010
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 06/2015
2	Coenzyme A (CoA)IBA 01/2017 - 06/2015
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2017 - 03/2014
2	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2017 - 11/2015
2	Simvastatin (Zocor)FDA LinkGeneric 01/2017 - 06/2016
2	Phosphodiesterase InhibitorsIBA 08/2016 - 11/2015
2	CholesterolIBA 11/2015 - 02/2013
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 05/2015 - 06/2010
2	Sildenafil Citrate (Viagra)FDA Link 05/2015 - 01/2014
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 05/2015 - 01/2005
2	Doxazosin (Cardura)FDA LinkGeneric 01/2014 - 05/2009
2	Protein Kinases (Protein Kinase)IBA 01/2014 - 01/2013

Therapy/Procedure

5	Therapeutics 02/2022 - 09/2007
3	Extracorporeal Shockwave Therapy 09/2021 - 01/2020